RecruitingNCT06278337
X-linked Moesin Associated Immunodeficiency
Studying Combined immunodeficiency due to Moesin deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Principal Investigator
- Isabelle ANDRE, doctorInstitut National de la Santé Et de la Recherche Médicale, France
- Intervention
- genetic restrospective study(genetic)
- Enrollment
- 16 enrolled
- Eligibility
- 4-80 years · MALE
- Timeline
- 2021 – 2027
Study locations (10)
- National Institutes of Health, Bethesda, Maryland, United States
- Perelman School of medecine, Philadelphia, Pennsylvania, United States
- Brown University, Providence, Rhode Island, United States
- Genomic Research Centre, School of Biomedical Sciences Institute of Health and Biomedical Innovation, Brisbane, Australia
- Hôpital Universitaire de la Reine Fabiola, Brussels, Belgium
- Hôpital Necker, Paris, PARIS, France
- CHU Rennes, CNRS UMR 629, Rennes, France
- CHU St Etienne Hôpital Nord, Saint-Etienne, France
- Tokyo Medical and Dental University (TMDU), Bunkyō City, Japan
- Departments of Internal Medicine and Immunology, Rotterdam, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06278337 on ClinicalTrials.gov